Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02023528 · ClinicalTrials.gov registry record
Dialysis Registry in Utah
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 243
- Enrollment target
NCT02023528: Completed study, sponsored by University of Utah.
NCT02023528 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 243 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02023528 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 243 participants
- Enrollment target
Study Summary
Based on the Medicare data, the 5-year survival of dialysis patients is only 39%. This is lower than that of stage IIIB breast cancer (54% 5-year survival). The annual mortality of dialysis patients is \~ 23% compared to \<0.1% in the United States general population. Even kidney transplant recipients have a substantially higher mortality (\~7%) compared to the general population. Consequently, the life-expectancy of dialysis and transplant populations is much lower than that of the general population. Cardiovascular events are the leading cause of death in dialysis patients and malnutrition is also a strong risk factor for death. The current proposal is to develop a prospective registry of incident dialysis patients at the University of Utah dialysis program to examine cardiovascular and nutritional factors in dialysis patients. This registry will include clinical and administrative data. In addition, blood samples will be stored for future analyses.
Primary Outcome
The objective is to develop a registry of incident dialysis patients at the University of Utah dialysis program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2008-01 |
| Est. Completion | 2015-12 |
What the finished NCT02023528 record still lists
NCT02023528 is an observational study that tracks outcomes without assigning an intervention. The registered 243 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02023528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02023528 about?
NCT02023528 is a clinical study titled "Dialysis Registry in Utah". Based on the Medicare data, the 5-year survival of dialysis patients is only 39%. This is lower than that of stage IIIB breast cancer (54% 5-year survival). The annual mortality of dialysis patients is \~ 23% compared to \<0.1% in the United States general population. Even kidney transplant recipien...
What is the current status of trial NCT02023528?
This trial is currently completed. The enrollment target is 243 participants. The study started on 2008-01. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02023528?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06253871 · 243 participants · Phase 1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NCT06289491 · 243 participants · NA
A Trial of Hydrus Microstent Versus Goniotomy
- NCT06536296 · 243 participants · NA
The Impact of Music Medicine on Preterm Brain Development and Behavior
- NCT06907615 · 243 participants · Phase 2
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia